<?xml-model href="http://dtd.nlm.nih.gov/publishing/3.0/rng/journalpublishing3.rng" schematypens="http://relaxng.org/ns/structure/1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bone Joint Res</journal-id><journal-id journal-id-type="iso-abbrev">Bone Joint Res</journal-id><journal-title-group><journal-title>Bone &#x00026; Joint Research</journal-title></journal-title-group><issn pub-type="ppub">2046-3758</issn><issn pub-type="epub">2046-3758</issn><publisher><publisher-name>British Editorial Society of Bone and Joint Surgery</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">25431439</article-id><article-id pub-id-type="pmc">4248299</article-id><article-id pub-id-type="doi">10.1302/2046-3758.311.2000336</article-id><article-id pub-id-type="publisher-id">2000336</article-id><article-categories><subj-group subj-group-type="heading"><subject>Hip</subject></subj-group><subj-group subj-group-type="hwp-journal-coll"><subject>1</subject></subj-group><subj-group subj-group-type="search-keyword"><subject>Femoroacetabular Impingment</subject><subject>Hip Arthroscopy</subject><subject>Physiotherapy</subject><subject>Randomised Controlled Trial</subject><subject>Osteoarthritis</subject></subj-group></article-categories><title-group><article-title>Protocol for the Femoroacetabular Impingement Trial (FAIT)</article-title><subtitle>a multi-centre randomised controlled trial comparing surgical and non-surgical management of femoroacetabular impingement</subtitle></title-group><contrib-group><contrib id="c1" contrib-type="author"><name><surname>Palmer</surname><given-names>A. J. R.</given-names></name><degrees>MA, BMBCh, MRCS</degrees><role>Orthopaedic Registrar, Clinical Research Fellow</role><xref ref-type="aff" rid="a1">1</xref><uri content-type="homepage" xlink:type="simple" xlink:href="http://orthodox.boneandjoint.org.uk/viewprofileinfo.aspx?authorid=1000308">http://orthodox.boneandjoint.org.uk/viewprofileinfo.aspx?authorid=1000308</uri></contrib><contrib id="c2" contrib-type="author"><name><surname>Ayyar-Gupta</surname><given-names>V.</given-names></name><degrees>MSc, PhD</degrees><role>Clinical
Trial Coordinator</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c3" contrib-type="author"><name><surname>Dutton</surname><given-names>S. J.</given-names></name><degrees>MSc</degrees><role>Senior Medical Statistician</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c4" contrib-type="author"><name><surname>Rombach</surname><given-names>I.</given-names></name><degrees>MSc</degrees><role>Clinical
Trials Statistician</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c5" contrib-type="author"><name><surname>Cooper</surname><given-names>C. D.</given-names></name><degrees>BN</degrees><role>Trial Manager</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c6" contrib-type="author"><name><surname>Pollard</surname><given-names>T. C.</given-names></name><degrees>BSc,
MD, FRCS</degrees><role>Consultant Orthopaedic Surgeon</role><xref ref-type="aff" rid="a6">2</xref></contrib><contrib id="c7" contrib-type="author"><name><surname>Hollinghurst</surname><given-names>D.</given-names></name><degrees>MA, MB, BChir, FRCS</degrees><role>Consultant Orthopaedic Surgeon</role><xref ref-type="aff" rid="a7">3</xref></contrib><contrib id="c8" contrib-type="author"><name><surname>Taylor</surname><given-names>A.</given-names></name><degrees>FRCS</degrees><role>Consultant
Orthopaedic Surgeon</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c9" contrib-type="author"><name><surname>Barker</surname><given-names>K. L.</given-names></name><degrees>MCSP,
MSc, PhD</degrees><role>Clinical Director, Head of Physiotherapy</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c10" contrib-type="author"><name><surname>McNally</surname><given-names>E. G.</given-names></name><degrees>MB, BCh,
BAO</degrees><role>Consultant Musculoskeletal Radiologist</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c11" contrib-type="author"><name><surname>Beard</surname><given-names>D. J.</given-names></name><degrees>MSc, DPhil</degrees><role>Professor of Musculoskeletal Sciences</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c12" contrib-type="author"><name><surname>Andrade</surname><given-names>A. J.</given-names></name><degrees>MSc FRCS</degrees><role>Consultant Orthopaedic Surgeon</role><xref ref-type="aff" rid="a6">2</xref></contrib><contrib id="c13" contrib-type="author"><name><surname>Carr</surname><given-names>A. J.</given-names></name><degrees>FRCS, FMedSci</degrees><role>Nuffield Professor of Orthopaedic Surgery</role><xref ref-type="aff" rid="a1">1</xref></contrib><contrib id="c14" contrib-type="author"><name><surname>Glyn-Jones</surname><given-names>S.</given-names></name><degrees>MA, DPhil, FRCS</degrees><role>Professor of Orthopaedic Surgery</role><xref ref-type="aff" rid="a1">1</xref></contrib><aff id="a1"><label>1</label>University of Oxford, Nuffield
Department of Orthopaedics, Rheumatology, and
Musculoskeletal Sciences, Windmill Road, Oxford, OX3
7LD, UK.</aff><aff id="a6"><label>2</label>Royal Berkshire Hospital, Reading, UK.</aff><aff id="a7"><label>3</label>Great Western Hospital, Swindon, UK.</aff></contrib-group><author-notes><corresp>Correspondence should be sent to Mr A. J.
R. Palmer; e-mail: <email>antony.palmer@ndorms.ox.ac.uk</email></corresp></author-notes><pub-date pub-type="collection"><month>11</month><year>2014</year></pub-date><pub-date pub-type="epub"><day>01</day><month>11</month><year>2014</year></pub-date><volume>3</volume><issue>11</issue><fpage>321</fpage><lpage>327</lpage><history><date date-type="received"><day>04</day><month>7</month><year>2014</year></date><date date-type="accepted"><day>03</day><month>9</month><year>2014</year></date></history><permissions><copyright-statement>&#x000a9;2014 The British Editorial Society of Bone &#x00026; Joint Surgery</copyright-statement><license license-type="open-access"><license-p>&#x000a9;2014 The British Editorial Society of Bone &#x00026; Joint Surgery. This is an open-access article distributed under the terms of the Creative Commons Attributions licence, which permits unrestricted use, distribution, and reproduction in any medium, but not for commercial gain, provided the original author and source are credited.</license-p></license></permissions><abstract><sec><title>Aims</title><p>Femoroacetabular Junction Impingement (FAI) describes abnormalities
in the shape of the femoral head&#x02013;neck junction, or abnormalities
in the orientation of the acetabulum. In the short term, FAI can
give rise to pain and disability, and in the long-term it significantly increases
the risk of developing osteoarthritis. The Femoroacetabular Impingement
Trial (FAIT) aims to determine whether operative or non-operative
intervention is more effective at improving symptoms and preventing
the development and progression of osteoarthritis. </p></sec><sec><title>Methods</title><p>FAIT is a multicentre superiority parallel two-arm randomised
controlled trial comparing physiotherapy and activity modification
with arthroscopic surgery for the treatment of symptomatic FAI.
Patients aged 18 to 60 with clinical and radiological evidence of
FAI are eligible. Principal exclusion criteria include previous
surgery to the index hip, established osteoarthritis (Kellgren&#x02013;Lawrence
&#x02265; 2), hip dysplasia (centre-edge angle &#x0003c; 20&#x000b0;), and completion
of a physiotherapy programme targeting FAI within the previous 12
months. Recruitment will take place over 24 months and 120 patients
will be randomised in a 1:1&#x000a0;ratio and followed up for three years.
The two primary outcome measures are change in hip outcome score
eight months post-randomisation (approximately six-months post-intervention
initiation) and change in radiographic minimum joint space width
38 months post-randomisation. ClinicalTrials.gov: NCT01893034.</p><p>Cite this article: <italic>Bone Joint Res</italic> 2014;3:321&#x02013;7.</p></sec></abstract><kwd-group><kwd>Femoroacetabular Impingment</kwd><kwd>Hip Arthroscopy</kwd><kwd>Physiotherapy</kwd><kwd>Randomised Controlled Trial</kwd><kwd>Osteoarthritis</kwd></kwd-group><funding-group><funding-statement>Support is received from the
NIHR Oxford Musculoskeletal Biomedical Research Unit, Thames Valley
Clinical Research Network, Arthritis Research UK Centre of Excellence
for Sports, Exercise and Osteoarthritis, a Royal College of Surgeons
and Dunhill Medical Trust Research Fellowship, and Orthopaedic Research
UK. The funding sources have no role in the design, execution, data
analysis, or publication of this study. Mr Andrade reports consultancy
fees and payment for lectures from Smith &#x00026; Nephew. Mr Hollinghurst
reports consultancy fees from Arthrex Stryker and Mr Taylor reports
payment for lectures from Teaching Zimmer/Corin, none of which are
related to this article.</funding-statement></funding-group><custom-meta-group><custom-meta><meta-name>odf2nlm-version</meta-name><meta-value>1.0</meta-value></custom-meta><custom-meta><meta-name>price</meta-name><meta-value>$2.00</meta-value></custom-meta><custom-meta><meta-name>principal-institution</meta-name><meta-value>Nuffield Department of Orthopaedics, Rheumatology, and Musculoskeletal Sciences, University of Oxford</meta-value></custom-meta><custom-meta><meta-name>article-type</meta-name><meta-value>Hip</meta-value></custom-meta><custom-meta><meta-name>coi-statement</meta-name><meta-value>None declared</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec><title>Introduction</title><p>Femoroacetabular impingement (FAI) describes morphological abnormalities
of the femoral head&#x02013;neck junction (cam impingement) or acetabulum
(pincer impingement). As a consequence of this abnormal morphology,
when the hip flexes and internally rotates, the femoral head&#x02013;neck
junction abuts the acetabular rim, resulting in labral damage and
delamination of the adjacent cartilage.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> In a study of 2081 young healthy adults,
35% of males and 10% of females displayed cam morphology, and 34%
of males and 17% of females displayed pincer morphology.<sup><xref rid="r2" ref-type="bibr">2</xref></sup> In the short-term,
FAI can give rise to pain and disability, and in the long term it
increases the risk of developing osteoarthritis.<sup><xref rid="r3" ref-type="bibr">3</xref></sup></p><p>Despite the considerable prevalence of FAI morphology, only a
proportion of individuals develop pain or osteoarthritis,<sup><xref rid="r3" ref-type="bibr">3</xref></sup> yet the condition
is responsible for a significant burden of disease. Predictive values
are dependent on the characteristics of the cohort, method used
to define the presence of FAI and length of follow-up. In an asymptomatic
population, the relative risk of developing hip pain within four
years in the presence of FAI morphology is 4.3 (95% confidence interval
(CI) 2.3 to 7.8) with a positive predictive value of 15.9%.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> The positive predictive
value for the development of osteoarthritis is estimated at 6% to
25%, with follow-up times of five<sup><xref rid="r5" ref-type="bibr">5</xref></sup> to 19&#x000a0;years.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> It remains unclear
whether pain secondary to FAI is a reliable predictor of future
osteoarthritis and low positive predictive values mean current clinical
care must focus on treating symptoms rather than preventing future
disease. Nevertheless, FAI is a potentially modifiable cause of
osteoarthritis, and cam lesions have been identified in more than
50% of patients undergoing total hip replacement.<sup><xref rid="r7" ref-type="bibr">7</xref></sup></p><p>There is uncertainty as to how symptomatic FAI is best treated<sup><xref rid="r8" ref-type="bibr">8</xref></sup> and the principal
two management options are physiotherapy with activity modification
or surgery. Both modalities have been shown to improve symptoms
in the short term,<sup><xref rid="r9" ref-type="bibr">9</xref>-<xref rid="r14" ref-type="bibr">14</xref></sup> however, no published
studies compare efficacy with each other or with sham procedures.
It is not known whether treatment provides sustained symptomatic
benefit in the long term, or whether it delays or prevents development
of osteoarthritis. These two treatment modalities were chosen as
comparators in a randomised controlled trial (RCT) after our feasibility
study demonstrated equipoise amongst clinicians specialising in
the field.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> The
feasibility study results have guided study design and the protocol
was drafted in accordance with the SPIRIT 2013 Statement.<sup><xref rid="r15" ref-type="bibr">15</xref></sup></p></sec><sec><title>Objectives</title><sec><title content-type="h3">Primary objectives</title><p>To determine whether arthroscopic surgery or physiotherapy and
activity modification is more effective in improving symptoms and
preventing the development and progression of osteoarthritis in patients
with symptomatic FAI. The co-primary outcome measures are change
in Hip Outcome Score (Activities of Daily Living Subscale)<sup><xref rid="r16" ref-type="bibr">16</xref></sup> eight months post-randomisation
and change in minimum joint space width (mJSW) (measured on anteroposterior
pelvic radiographs)<sup><xref rid="r17" ref-type="bibr">17</xref></sup> 38&#x000a0;months
post-randomisation. </p></sec><sec><title content-type="h3">Secondary objectives</title><p>To compare cost effectiveness of physiotherapy and activity modification
with arthroscopic surgery.</p><p>To evaluate the performance of disease biomarkers (physiological
MRI, urine, serum and synovial biochemical markers).</p></sec></sec><sec sec-type="materials|methods"><title>Materials and Methods</title><sec><title content-type="h3">Study design</title><p>The Femoroacetabular Impingement Trial (FAIT) is an assessor-blinded
multicentre superiority parallel two-arm RCT comparing physiotherapy
and activity modification with arthroscopic surgery for the treatment of
symptomatic FAI.</p></sec><sec><title content-type="h3">Comparators</title><p>Non-operative treatment of FAI aims to minimise impingement through
avoidance of activities that require repeated hip flexion and modification
of joint biomechanics. Improving core stability and movement control,
with particular emphasis on strengthening external rotator and abductor
muscle groups<sup><xref rid="r9" ref-type="bibr">9</xref></sup> is
thought to limit forceful impaction of the femoral neck against
the acetabular rim. Physiotherapy represents first line care in many
centres as a result of available expertise, local funding allowances
or clinician preference based on existing evidence. It describes
a heterogeneous group of therapies, and a standardised treatment
protocol for this study was agreed by a panel of specialists based
on experience and current literature.</p><p>Either open or arthroscopic surgery can be performed to re-contour
the femoral neck or acetabular rim by burring away the impinging
bone. The number of surgical procedures performed in England to
treat FAI has increased by 442% over the past ten years.<sup><xref rid="r18" ref-type="bibr">18</xref></sup> Arthroscopic surgery
is performed more than twice as frequently as open surgery and studies
show that it carries lower rates of complication with outcomes equal
to or better than alternatives.<sup><xref rid="r19" ref-type="bibr">19</xref></sup> Arthroscopic
surgery was therefore adopted as the comparator and low complication
rates<sup><xref rid="r20" ref-type="bibr">20</xref></sup> make
it a potentially acceptable alternative to physiotherapy and activity
modification.</p><p>Sham surgery was considered as a third treatment arm, however,
it was felt this would make recruitment difficult. A survey of orthopaedic
surgeons in Canada revealed only 24.8% supported a sham surgery
control arm.<sup><xref rid="r21" ref-type="bibr">21</xref></sup></p></sec><sec><title content-type="h3">Participants</title><p>Eligible patients will be symptomatic, aged 18 to 60 years and
have clinical and radiolographic evidence of FAI. Exclusion criteria
include radiological evidence of established osteoarthritis (Kellgren&#x02013;Lawrence<sup><xref rid="r16" ref-type="bibr">16</xref></sup> &#x02265;&#x000a0;2) or hip dysplasia
(centre&#x02013;edge angle &#x0003c; 20<sup>o</sup>) on anteroposterior pelvic
radiographs, as these individuals are less likely to benefit from
the study interventions;<sup><xref rid="r14" ref-type="bibr">14</xref></sup> previous surgery
to the index hip or completion of a physiotherapy programme targeting
FAI within the last year, in order to counter selection bias towards
patients who have failed prior intervention; medical conditions
that prevent surgical intervention and contraindications to MRI
(Table I). Patients will be offered continued participation should contraindications
to imaging arise during follow-up, for example, pregnancy. In such
circumstances, contraindicated imaging modalities will be omitted
for any particular visit.</p><table-wrap id="t1" orientation="portrait" position="float"><label>Table I</label><caption><p><bold>Table I:</bold> Inclusion and exclusion criteria</p></caption><table frame="hsides" rules="groups"><thead><tr><th rowspan="1" colspan="1"><bold>Inclusion criteria</bold></th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1"><bold>Exclusion criteria</bold></th></tr></thead><tbody><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Patient with symptomatic FAI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Previous surgery to index hip</td></tr><tr><td rowspan="1" colspan="1">Age 18 to 60</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Established osteoarthritis (Kellgren&#x02013;Lawrence &#x02265; 2)</td></tr><tr><td rowspan="1" colspan="1">Clinical and radiological evidence 
of FAI</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Hip dysplasia (centre&#x02013;edge angle &#x0003c;&#x000a0;20<sup>&#x000b0;</sup> on anteroposterior
radiograph)</td></tr><tr><td rowspan="1" colspan="1">Competent to consent</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Completion of physiotherapy programme targeting FAI within preceding
12&#x000a0;months </td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Medical conditions that preclude surgical intervention </td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Contraindication to MRI</td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn><p>
FAI, femoroacetabular impingement
</p></fn></table-wrap-foot></table-wrap></sec><sec><title content-type="h3">Recruitment</title><p>Patients will be recruited from NHS clinics of at least three
hospitals in England including teaching hospitals and district general
hospitals. A member of the surgical team will introduce the trial
to eligible patients, and if they would like more information, they
will be introduced to a member of the research team at this initial
clinic appointment. Patients opt in by providing their contact details
and written consent to be approached again once they have had at
least 48 hours to consider the information. A baseline assessment
will take place approximately four weeks after the initial approach.
Consent and randomisation will take place at this baseline visit.</p></sec><sec><title content-type="h3">Assignment of treatment</title><p>Patients will be randomly assigned to hip arthroscopy or physiotherapy
with 1:1 allocation using a telephone system provided by the Oxford
Clinical Trials Unit. Simple randomisation is used for the first
12 patients followed by minimisation with a random element (p =
0.8) and using stratification factors: age (&#x0003c; 40 or &#x02265; 40 years),
gender, recruitment site and baseline activities of daily living
(ADL) hip outcome score (HOS)<sup><xref rid="r22" ref-type="bibr">22</xref></sup> subscale
(&#x0003c; 65 or &#x02265; 65). The HOS threshold is derived from baseline scores
in comparable cohorts.<sup><xref rid="r23" ref-type="bibr">23</xref>,<xref rid="r24" ref-type="bibr">24</xref></sup></p></sec></sec><sec><title>Interventions</title><sec><title content-type="h3">Non-operative intervention: physiotherapy
and activity modification</title><p>Participants will receive physiotherapy following a goal-based
programme with up to eight sessions over five months. During the
initial assessment, goals will be agreed between the patient and
physiotherapist based on the individual needs of the patient and
their desired level of function. The physiotherapy programme will
aim to address these goals alongside a standardised treatment checklist
that places emphasis on muscle strengthening to improve core stability
and movement control. Treatment will be led by physiotherapists
who have received training for this study during site visits to
ensure treatment standardisation. Patients are encouraged to continue
exercises at home and to refrain from activities requiring the extremes
of hip flexion, abduction and internal rotation (impingement position).
Patient attendance and compliance with the treatment plan will be
recorded. Should participants achieve all their goals within five
months, they will be discharged and asked to continue their exercises
and activity modification in the community. There will be no physiotherapy
sessions in the four weeks preceding follow-up appointments to ensure
symptoms are stable when assessed.</p></sec><sec><title content-type="h3">Operative: hip arthroscopy</title><p>Participating surgeons perform over 100 hip arthroscopies each
year and will meet prior to commencing recruitment to ensure standardisation
of technique. Hip morphology will be assessed intra-operatively
under arthroscopic vision and fluoroscopy. Bone that is seen to
be causing impingement on flexing, abducting and internally rotating
the hip will be excised with a burr. Damage to the labrum or articular
cartilage will also be addressed: labral tears will be repaired
if possible using anchors, or otherwise debrided. Articular cartilage
damage will be debrided to a stable base, and in areas of full thickness
loss, microfracture will be performed. Microfracture involves the creation
of small holes in the subchondral bone to facilitate cartilage regeneration.
Patients will be discharged home once medically fit and after assessment
by the physiotherapy team. They will be allowed to fully-weight
bear immediately after surgery unless they received microfracture,
when they will be required to touch-weight-bear for three weeks,
partial-weight-bear for three weeks, and then fully-weight-bear.
Participants will be asked to avoid high-impact exercise for eight&#x000a0;weeks
unless they received microfracture, at which point, this increases
to 12 weeks. There will be no restriction in the range of movement
permitted post-operatively. Patients will be reviewed in the NHS
clinic of their surgeon six weeks after surgery to monitor for surgical complications.
Follow-up thereafter is with the study team. Participants who undergo
surgery follow a routine physiotherapy programme post-operatively
that focuses on rehabilitation and maintaining a functional range
of movement. This is a different regime to that employed for the
non-operative intervention. The number of sessions and duration
of treatment will depend on individual patient requirements. Patients
will be discharged once they have regained their desired level of function
or their improvement has plateaued. There will be no physiotherapy
sessions in the four weeks preceding follow-up appointments as per
the non-surgical treatment arm. </p></sec><sec><title content-type="h3">Treatment modification</title><p>The primary outcome will be measured eight months post-randomisation
and crossover is not permitted before this assessment. Any time thereafter,
if a participant feels they have not reached their goals and seek
further intervention with respect to their index hip, they will
be reviewed by a member of the recruiting surgical team and offered
entry into the alternative treatment arm. </p></sec><sec><title content-type="h3">Concomitant care</title><p>Intra-articular steroid injections are not permitted after recruitment
into the study as these may limit the ability to compare efficacy
of the study treatment arms. All other concomitant treatments are permitted.</p></sec></sec><sec><title>Study outcomes</title><sec><title content-type="h3">Primary outcome measures: improvement
of symptoms</title><p>The primary outcome measure is change in the hip outcome score
(HOS),<sup><xref rid="r20" ref-type="bibr">20</xref></sup> which
was specifically designed as an outcome instrument for hip arthroscopy
and is considered the most reliable and valid measure of self-reported
physical function in this population.<sup><xref rid="r25" ref-type="bibr">25</xref></sup> It comprises subscales for ADL and
sport, and this study is powered to detect a difference in ADL.
The primary outcome will be measured eight months post-randomisation,
equating to approximately six months after intervention commences.
This time point was chosen since i) a clinically meaningful difference
in the ADL HOS of nine points is detectable six&#x000a0;months after hip
arthroscopy;<sup><xref rid="r23" ref-type="bibr">23</xref></sup> ii)
our feasibility study showed that 94% of patients are happy to trial
a treatment for six months, but no longer, without improvement in their
symptoms<sup><xref rid="r8" ref-type="bibr">8</xref></sup> and
iii) this reflects current routine clinic appointment scheduling
and increases clinical relevance. An audit of outcomes at the co-ordinating
centre demonstrated that the majority of symptom improvement takes place
within six months of intervention, although improvement continues
beyond 12&#x000a0;months. This finding has also been demonstrated in other
centres.<sup><xref rid="r26" ref-type="bibr">26</xref></sup></p></sec><sec><title content-type="h3">Primary outcome measures: prevention
of osteoarthritis</title><p>Change in radiographic mJSW 38 months post-randomisation is also
a primary outcome measure. Measurements will be performed by trained
readers on standing anteroposterior pelvic radiographs using a validated
software package (HipMorf 2.0, University of Oxford, Oxford, UK).
Three-year follow-up is selected as responsiveness to change of
this measurement improves significantly in studies exceeding two
years.<sup><xref rid="r27" ref-type="bibr">27</xref>,<xref rid="r28" ref-type="bibr">28</xref></sup>
</p></sec><sec><title content-type="h3">Secondary outcome measures: improvement
of symptoms</title><p>Evidence for reliability, validity and responsiveness of patient-reported
outcome measures (PROMS) in FAI is limited<sup><xref rid="r29" ref-type="bibr">29</xref></sup> and the following additional PROMs
will be collected as secondary outcome measures: non-arthritic hip score
(NAHS),<sup><xref rid="r30" ref-type="bibr">30</xref></sup> international
hip outcome score (iHOT-33),<sup><xref rid="r31" ref-type="bibr">31</xref></sup> hip
and groin outcome score (HAGOS),<sup><xref rid="r32" ref-type="bibr">32</xref></sup> and Oxford
hip score (OHS).<sup><xref rid="r33" ref-type="bibr">33</xref></sup> PainDETECT<sup><xref rid="r34" ref-type="bibr">34</xref></sup> will be used to establish
the nature and location of pain. Psychological factors will be assessed
using the hospital and anxiety depression scale (HADS).<sup><xref rid="r35" ref-type="bibr">35</xref></sup> At baseline, in
addition to the HOS relating to current symptoms, patients will
be asked to complete an additional HOS to indicate the symptoms
they expect to experience after treatment is complete. The aim of
this questionnaire is to determine how well treatment outcome meets
expectations.</p></sec><sec><title content-type="h3">Secondary outcome measures: prevention
of osteoarthritis</title><p>Alternative measures of osteoarthritis may confer advantages
over radiographic mJSW,<sup><xref rid="r17" ref-type="bibr">17</xref></sup> and
secondary outcome measures include regional changes in JSW, Kellgren&#x02013;Lawrence
grading, cartilage morphology on MRI and whole-joint semi-quantitative
measures of osteoarthritis.<sup><xref rid="r36" ref-type="bibr">36</xref></sup> Though
the primary outcome measure is change in mJSW, the proportion of
progressors in each treatment arm will also be calculated.</p></sec><sec><title content-type="h3">Secondary outcome measures: health
economics</title><p>Health outcomes will be assessed at each trial follow-up using
the EuroQol EQ-5D questionnaire<sup><xref rid="r37" ref-type="bibr">37</xref></sup> and
collection of information pertaining to the delivery of health care and
ability of patients to work. The main health economic outcome is
net cost per quality-adjusted life year gained. Full details are
included in the &#x02018;health economic analysis plan&#x02019; that will be finalised
prior to the unblinding of the data for analysis.</p></sec></sec><sec><title>Exploratory outcome measures </title><sec><title content-type="h3">Evaluation of disease biomarkers</title><p>A number of novel biomarkers have been proposed for the evaluation
of early osteoarthritis. These offer potential as tools to diagnose
the earliest osteoarthritis when disease remains potentially reversible,
and as measures of treatment efficacy within short timeframes. However,
further validation is essential. The MRI protocol for this study
includes T2 mapping and T1 Rho sequences that assess the biochemical
composition of cartilage.<sup><xref rid="r38" ref-type="bibr">38</xref></sup> Fasting
serum and urine samples will be collected at study assessments to
measure markers of cartilage metabolism.<sup><xref rid="r39" ref-type="bibr">39</xref></sup> Synovial fluid will be collected
at the time of surgery if an effusion is present, and used to validate
serum and urine biomarkers. The performance of the biomarkers will
be assessed through their relationship with primary and secondary outcome
measures.</p></sec><sec><title content-type="h3">Assessment schedule</title><p>Outcome measure collection will be scheduled post-randomisation
(Fig. 1). Intervention will commence approximately eight weeks after
randomisation. This equates to 12 weeks after patients were first seen
in clinic, in line with average waiting times for treatment at participating
centres. Deviations from this schedule will be explored to seek
possible solutions, particularly in relation to differences in waiting
times for each treatment arm. On the day intervention commences,
clinical examination and collection of PROM data will be repeated
to enable evaluation of the stability of symptoms and signs. The
acceptable window for appointments is four weeks either side of
the calculated date. As a contingency, to ensure outcome measures
are assessed at an appropriate time point after intervention, if treatment
is delayed and commences more than 12&#x000a0;weeks post-randomisation,
the assessment schedule will be shifted to a post-intervention timescale.
This also ensures follow-up coincides with routine hospital visits. The
HOS will continue to be collected at eight and 14 months post-randomisation
via postal questionnaire to allow comparison between assessment
schedules. The study is designed with regular follow-up to map symptom
fluctuation<sup><xref rid="r40" ref-type="bibr">40</xref></sup> and
the trajectory of improvement in this population.</p><fig id="f1" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Femoroacetabular Impingement Trial (FAIT)
flowchart.</p></caption><graphic xlink:href="2000336-galleyfig1"/></fig></sec><sec><title content-type="h3">Masking</title><p>Trial co-ordinators and those providing clinical care will not
be masked to treatment allocation, however, all members of the research
team performing post-randomisation clinical assessments will be
blinded. Participants will be asked not to disclose their treatment
and will wear shorts to cover any scars. Data entry will be performed
by staff members independent of the study team. Blinding will be
maintained when performing assays of biochemical biomarkers and
imaging study interpretation.</p></sec></sec><sec><title>Statistical analysis</title><sec><title content-type="h3">Measure of outcome</title><p>Trial statisticians will conduct all analyses and all reporting
will follow CONSORT guidelines. Primary analysis will be based on
the &#x02018;intention to treat&#x02019; population of all randomised participants
regardless of their compliance with the protocol. Hypothesis tests
will be two-sided with a 5% significance level. Study analysis will
take place in two stages: i)&#x000a0;after all participants have completed
their eight-month post-randomisation assessment and ii)&#x000a0;after all
follow-up is complete. Linear regression analysis (ANCOVA) will
be used to examine differences between treatment arms for change in
the ADL HOS at eight months and mJSW at 38&#x000a0;months in multivariate
frameworks, adjusting for baseline minimisation factors and other
relevant patient characteristics. Diagnostic checks will be performed
to verify model assumptions. Secondary outcome measures will be analysed
using linear (for continuous outcomes) or logistic (for binary outcomes)
multivariate regression with appropriate covariate adjustment. Secondary
analysis of PROMS will take into account the multiple data points using
random effects regression methodology. Subgroup analysis will include
measures of osteoarthritis on baseline imaging and at arthroscopy,
given that studies suggest this is an important predictor of outcome.<sup><xref rid="r41" ref-type="bibr">41</xref></sup> Missing data patterns
will be explored and addressed according to current best practice.
Further details are included in the &#x02018;statistical analysis plan&#x02019;
that will be finalised prior to the unblinding of the data for analysis.</p></sec><sec><title content-type="h3">Sample size</title><p>This study is powered to detect a clinically important difference
in the HOS ADL subscale eight&#x000a0;months post-randomisation. The minimal
clinically important difference is nine points<sup><xref rid="r23" ref-type="bibr">23</xref></sup> with a standard deviation
of 14 at six months post-intervention.<sup><xref rid="r26" ref-type="bibr">26</xref></sup> Using a statistical significance
of 5% and a power of 90%, 51&#x000a0;patients are required for each arm.
Accounting for a possible 15% loss to follow-up, 60 patients will
be recruited to each arm (total 120 patients). This sample size
is also sufficient to detect a clinically important change in mJSW
at three years<sup><xref rid="r42" ref-type="bibr">42</xref></sup> with
a statistical significance of 5% and power of 90% where the minimum
clinically important difference is 0.5mm<sup><xref rid="r28" ref-type="bibr">28</xref></sup> and standard deviation 0.62.<sup><xref rid="r43" ref-type="bibr">43</xref></sup></p><p>Patients frequently present with bilateral symptoms secondary
to FAI and the most symptomatic hip will be treated first. Should
a patient seek treatment for their contralateral hip whilst follow-up
continues for their study hip, this hip will not be included in
the trial but the same study outcome measures will be collected
until 38-month follow-up is complete for the study hip. These results
will be used in the data analysis for covariate adjustment. Treatment
allocation for the contralateral hip will be through patient choice,
given i) results from this hip will not be used in the primary analysis,
ii) clinicians remain in equipoise with respect to treatment allocation,
or iii) patients may have a strong treatment preference based on
results of the intervention already received, hence aiding patient
retention. Treatment of the contralateral hip will not commence
until the eight-month post-randomisation assessment is complete
for the study hip. </p></sec></sec><sec><title>Organisation</title><sec><title content-type="h3">Monitoring</title><p>A data monitoring committee (DMC) will review accumulating data
and make recommendations to the trial steering committee (TSC) with
respect to trial conduct and participant safety. DMC and TSC charters outline
the roles and responsibilities of these committees. Power calculations
will be validated by comparing the standard deviation of the ADL
HOS baseline data, with values used for sample size calculations.
Sample size may be increased based on these findings and treatment
effect will not be considered until recruitment is complete.</p></sec><sec><title content-type="h3">Trial status</title><p>Recruitment commenced in July 2013 and is anticipated to conclude
in June 2015. At the time of submission, 62 patients have been randomised
and 14 have completed eight-month follow-up.</p></sec></sec><sec><title>Conclusion</title><p>Equipoise exists among clinicians treating FAI and the results
of this study will guide clinical management of the condition.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> Surgical treatment
of FAI is not funded by the NHS in many regions. Should surgery
demonstrate superior efficacy over physiotherapy at improving symptoms and
preventing the development of osteoarthritis, with a favourable
health economic analysis, it may be appropriate to review these
funding decisions.</p></sec></body><back><fn-group content-type="bjr-block"><fn fn-type="con"><p><bold>Author contributions:</bold>A. J. R. Palmer: Study design, Study implementation and refinement
of the study protocol, Approved the final manuscript, Principal
Investigator.</p><p> V. Ayyar-Gupta: Study implementation and refinement of the
study protocol, Approved the final manuscript.</p><p>S. J. Dutton: Expertise in trial statistics, refinement of the
study protocol, Approved the final manuscript.</p><p>I. Rombach: Expertise in trial statistics, refinement of the
study protocol, Approved the final manuscript.</p><p>C. D. Cooper: Study implementation, refinement of the study protocol,
Approved the final manuscript.</p><p>T. C. Pollard: Refinement of the study protocol, Approved the
final manuscript.</p><p>D. Hollinghurst: Refinement of the study protocol, Approved the
final manuscript.</p><p>A. Taylor: Refinement of the study protocol, Approved the final
manuscript.</p><p>K. L. Barker: Expertise in physiotherapy, refinement of the study
protocol, Approved the final manuscript.</p><p>E. G. McNally: Expertise in imaging, refinement of the study
protocol, Approved the final manuscript.</p><p>D. J. Beard: Expertise in clinical trial methodology, refinement
of the study protocol, Approved the final manuscript.</p><p>A. J. Andrade: Refinement of the study protocol, Approved the
final manuscript.</p><p>A. J. Carr: Refinement of the study protocol, Approved the final
manuscript.</p><p>S. Glyn-Jones: Conceived study idea, study design, refinement
of the study protocol, Approved the final manuscript, Chief Investigator.</p></fn><fn fn-type="conflict"><p><bold>ICMJE Conflict of Interest:</bold>None declared.</p></fn></fn-group><ref-list><ref id="r1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Ganz</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Parvizi</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Beck</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Femoroacetabular impingement: a cause for osteoarthritis of the hip</article-title>. <source>Clin Orthop Relat Res</source><year>2003</year>;<volume>417</volume>:<fpage>112</fpage>&#x02013;<lpage>120</lpage>.<pub-id pub-id-type="pmid">14646708</pub-id></mixed-citation></ref><ref id="r2"><label>2</label><mixed-citation publication-type="journal"><string-name><surname>Laborie</surname>
<given-names>LB</given-names></string-name>, <string-name><surname>Lehmann</surname>
<given-names>TG</given-names></string-name>, <string-name><surname>Enges&#x000e6;ter</surname>
<given-names>I&#x000d8;</given-names></string-name>, <etal/>
<article-title>Prevalence of radiographic findings thought to be associated with femoroacetabular impingement in a population-based cohort of 2081 healthy young adults</article-title>. <source>Radiology</source><year>2011</year>;<volume>260</volume>:<fpage>494</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">21613440</pub-id></mixed-citation></ref><ref id="r3"><label>3</label><mixed-citation publication-type="journal"><string-name><surname>Agricola</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Waarsing</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Arden</surname>
<given-names>NK</given-names></string-name>. <article-title>, et al. Cam impingement of the hip: a risk factor for hip osteoarthritis</article-title>. <source>Nat Rev Rheumatol</source><year>2013</year>;<volume>9</volume>:<fpage>630</fpage>&#x02013;<lpage>634</lpage>.<pub-id pub-id-type="pmid">23881070</pub-id></mixed-citation></ref><ref id="r4"><label>4</label><mixed-citation publication-type="journal"><string-name><surname>Khanna</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Caragianis</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Diprimio</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Rakhra</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Beaul&#x000e9;</surname>
<given-names>PE</given-names></string-name>. <article-title>Incidence of hip pain in a prospective cohort of asymptomatic volunteers: is the cam deformity a risk factor for hip pain?</article-title><source>Am J Sports Med</source><year>2014</year>;<volume>42</volume>:<fpage>793</fpage>&#x02013;<lpage>797</lpage>.<pub-id pub-id-type="pmid">24481825</pub-id></mixed-citation></ref><ref id="r5"><label>5</label><mixed-citation publication-type="journal"><string-name><surname>Agricola</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Heijboer</surname>
<given-names>MP</given-names></string-name>, <string-name><surname>Bierma-Zeinstra</surname>
<given-names>SM</given-names></string-name>, <etal/>
<article-title>Cam impingement causes osteoarthritis of the hip: a nationwide prospective cohort study (CHECK)</article-title>. <source>Ann Rheum Dis</source><year>2013</year>;<volume>72</volume>:<fpage>918</fpage>&#x02013;<lpage>923</lpage>.<pub-id pub-id-type="pmid">22730371</pub-id></mixed-citation></ref><ref id="r6"><label>6</label><mixed-citation publication-type="journal"><string-name><surname>Nicholls</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Kiran</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Pollard</surname>
<given-names>TC</given-names></string-name>, <etal/>
<article-title>The association between hip morphology parameters and nineteen-year risk of end-stage osteoarthritis of the hip: a nested case-control study</article-title>. <source>Arthritis Rheum</source><year>2011</year>;<volume>63</volume>:<fpage>3392</fpage>&#x02013;<lpage>3400</lpage>.<pub-id pub-id-type="pmid">21739424</pub-id></mixed-citation></ref><ref id="r7"><label>7</label><mixed-citation publication-type="journal"><string-name><surname>Clohisy</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Dobson</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Robison</surname>
<given-names>JF</given-names></string-name>, <etal/>
<article-title>Radiographic structural abnormalities associated with premature, natural hip-joint failure</article-title>. <source>J Bone Joint Surg [Am]</source><year>2011</year>;<volume>93-A(Suppl 2)</volume>:<fpage>3</fpage>&#x02013;<lpage>9</lpage>.</mixed-citation></ref><ref id="r8"><label>8</label><mixed-citation publication-type="journal"><string-name><surname>Palmer</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>GE</given-names></string-name>, <string-name><surname>Pollard</surname>
<given-names>TC</given-names></string-name>, <etal/>
<article-title>The feasibility of performing a randomised controlled trial for femoroacetabular impingement surgery</article-title>. <source>Bone Joint Res</source><year>2013</year>;<volume>2</volume>:<fpage>33</fpage>&#x02013;<lpage>40</lpage>.<pub-id pub-id-type="pmid">23610700</pub-id></mixed-citation></ref><ref id="r9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Wall</surname>
<given-names>PD</given-names></string-name>, <string-name><surname>Fernandez</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Griffin</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Foster</surname>
<given-names>NE</given-names></string-name>. <article-title>Nonoperative treatment for femoroacetabular impingement: a systematic review of the literature</article-title>. <source>PM R</source><year>2013</year>;<volume>5</volume>:<fpage>418</fpage>&#x02013;<lpage>426</lpage>.<pub-id pub-id-type="pmid">23419746</pub-id></mixed-citation></ref><ref id="r10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Bedi</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Chen</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Robertson</surname>
<given-names>W</given-names></string-name>, <string-name><surname>Kelly</surname>
<given-names>BT</given-names></string-name>. <article-title>The management of labral tears and femoroacetabular impingement of the hip in the young, active patient</article-title>. <source>Arthroscopy</source><year>2008</year>;<volume>24</volume>:<fpage>1135</fpage>&#x02013;<lpage>1145</lpage>.<pub-id pub-id-type="pmid">19028166</pub-id></mixed-citation></ref><ref id="r11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Ng</surname>
<given-names>VY</given-names></string-name>, <string-name><surname>Arora</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Best</surname>
<given-names>TM</given-names></string-name>, <string-name><surname>Pan</surname>
<given-names>X</given-names></string-name>, <string-name><surname>Ellis</surname>
<given-names>TJ</given-names></string-name>. <article-title>Efficacy of surgery for femoroacetabular impingement: a systematic review</article-title>. <source>Am J Sports Med</source><year>2010</year>;<volume>38</volume>:<fpage>2337</fpage>&#x02013;<lpage>2345</lpage>.<pub-id pub-id-type="pmid">20489213</pub-id></mixed-citation></ref><ref id="r12"><label>12</label><mixed-citation publication-type="journal"><string-name><surname>Clohisy</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>St John</surname>
<given-names>LC</given-names></string-name>, <string-name><surname>Schutz</surname>
<given-names>AL</given-names></string-name>. <article-title>Surgical treatment of femoroacetabular impingement: a systematic review of the literature</article-title>. <source>Clin Orthop Relat Res</source><year>2010</year>;<volume>468</volume>:<fpage>555</fpage>&#x02013;<lpage>564</lpage>.<pub-id pub-id-type="pmid">19830504</pub-id></mixed-citation></ref><ref id="r13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Gedouin</surname>
<given-names>JE</given-names></string-name>, <string-name><surname>May</surname>
<given-names>O</given-names></string-name>, <string-name><surname>Bonin</surname>
<given-names>N</given-names></string-name>, <etal/>
<article-title>Assessment of arthroscopic management of femoroacetabular impingement. A prospective multicenter study</article-title>. <source>Orthop Traumatol Surg Res</source><year>2010</year>;<volume>96(8 Suppl)</volume>:<fpage>S59</fpage>&#x02013;<lpage>S67</lpage>.<pub-id pub-id-type="pmid">21035415</pub-id></mixed-citation></ref><ref id="r14"><label>14</label><mixed-citation publication-type="journal"><string-name><surname>Philippon</surname>
<given-names>MJ</given-names></string-name>, <string-name><surname>Briggs</surname>
<given-names>KK</given-names></string-name>, <string-name><surname>Yen</surname>
<given-names>YM</given-names></string-name>, <string-name><surname>Kuppersmith</surname>
<given-names>DA</given-names></string-name>. <article-title>Outcomes following hip arthroscopy for femoroacetabular impingement with associated chondrolabral dysfunction: minimum two-year follow-up</article-title>. <source>J Bone Joint Surg [Br]</source><year>2009</year>;<volume>91-B</volume>:<fpage>16</fpage>&#x02013;<lpage>23</lpage>.</mixed-citation></ref><ref id="r15"><label>15</label><mixed-citation publication-type="journal"><string-name><surname>Chan</surname>
<given-names>AW</given-names></string-name>, <string-name><surname>Tetzlaff</surname>
<given-names>JM</given-names></string-name>, <string-name><surname>Altman</surname>
<given-names>DG</given-names></string-name>, <etal/>
<article-title>SPIRIT 2013 statement: defining standard protocol items for clinical trials</article-title>. <source>Ann Intern Med</source><year>2013</year>;<volume>158</volume>:<fpage>200</fpage>&#x02013;<lpage>207</lpage>.<pub-id pub-id-type="pmid">23295957</pub-id></mixed-citation></ref><ref id="r16"><label>16</label><mixed-citation publication-type="journal"><string-name><surname>Kellgren</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Lawrence</surname>
<given-names>JS</given-names></string-name>. <article-title>Radiological assessment of osteo-arthrosis</article-title>. <source>Ann Rheum Dis</source><year>1957</year>;<volume>16</volume>:<fpage>494</fpage>&#x02013;<lpage>502</lpage>.<pub-id pub-id-type="pmid">13498604</pub-id></mixed-citation></ref><ref id="r17"><label>17</label><mixed-citation publication-type="journal"><string-name><surname>Conaghan</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Hunter</surname>
<given-names>DJ</given-names></string-name>, <string-name><surname>Maillefert</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Reichmann</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Losina</surname>
<given-names>E</given-names></string-name>. <article-title>Summary and recommendations of the OARSI FDA osteoarthritis Assessment of Structural Change Working Group</article-title>. <source>Osteoarthritis Cartilage</source><year>2011</year>;<volume>19</volume>:<fpage>606</fpage>&#x02013;<lpage>610</lpage>.<pub-id pub-id-type="pmid">21396466</pub-id></mixed-citation></ref><ref id="r18"><label>18</label><mixed-citation publication-type="journal"><string-name><surname>Palmer</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Thomas</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Whitwell</surname>
<given-names>D</given-names></string-name>, <etal/>
<article-title>Temporal Trends in Arthroscopy and Joint Preserving Surgery of the Hip from 2001 to 2010: A Study of 12,684 Procedures using the HES Database</article-title>. <source>Bone Joint J</source><year>2013</year>;<volume>95-B(Supp 1)</volume>:<fpage>96</fpage>.</mixed-citation></ref><ref id="r19"><label>19</label><mixed-citation publication-type="journal"><string-name><surname>Matsuda</surname>
<given-names>DK</given-names></string-name>, <string-name><surname>Carlisle</surname>
<given-names>JC</given-names></string-name>, <string-name><surname>Arthurs</surname>
<given-names>SC</given-names></string-name>, <string-name><surname>Wierks</surname>
<given-names>CH</given-names></string-name>, <string-name><surname>Philippon</surname>
<given-names>MJ</given-names></string-name>. <article-title>Comparative systematic review of the open dislocation, mini-open, and arthroscopic surgeries for femoroacetabular impingement</article-title>. <source>Arthroscopy</source><year>2011</year>;<volume>27</volume>:<fpage>252</fpage>&#x02013;<lpage>269</lpage>.<pub-id pub-id-type="pmid">21266276</pub-id></mixed-citation></ref><ref id="r20"><label>20</label><mixed-citation publication-type="journal"><string-name><surname>Papavasiliou</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bardakos</surname>
<given-names>NV</given-names></string-name>. <article-title>Complications of arthroscopic surgery of the hip</article-title>. <source>Bone Joint Res</source><year>2012</year>;<volume>1</volume>:<fpage>131</fpage>&#x02013;<lpage>144</lpage>.<pub-id pub-id-type="pmid">23610683</pub-id></mixed-citation></ref><ref id="r21"><label>21</label><mixed-citation publication-type="journal"><string-name><surname>Ayeni</surname>
<given-names>OR</given-names></string-name>, <string-name><surname>Belzile</surname>
<given-names>EL</given-names></string-name>, <string-name><surname>Musahl</surname>
<given-names>V</given-names></string-name>, <etal/>
<article-title>Results of the PeRception of femOroaCetabular impingEment by Surgeons Survey (PROCESS)</article-title>. <source>Knee Surg Sports Traumatol Arthrosc</source><year>2014</year>;<volume>22</volume>:<fpage>906</fpage>&#x02013;<lpage>910</lpage>.<pub-id pub-id-type="pmid">24509882</pub-id></mixed-citation></ref><ref id="r22"><label>22</label><mixed-citation publication-type="journal"><string-name><surname>Martin</surname>
<given-names>RL</given-names></string-name>. <article-title>Hip Arthroscopy and Outcome Assessment</article-title>. <source>Operative Techniques in Orthopaedics</source><year>2005</year>;<volume>15</volume>:<fpage>290</fpage>&#x02013;<lpage>296</lpage>.</mixed-citation></ref><ref id="r23"><label>23</label><mixed-citation publication-type="journal"><string-name><surname>Martin</surname>
<given-names>RL</given-names></string-name>, <string-name><surname>Philippon</surname>
<given-names>MJ</given-names></string-name>. <article-title>Evidence of reliability and responsiveness for the hip outcome score</article-title>. <source>Arthroscopy</source><year>2008</year>;<volume>24</volume>:<fpage>676</fpage>&#x02013;<lpage>682</lpage>.<pub-id pub-id-type="pmid">18514111</pub-id></mixed-citation></ref><ref id="r24"><label>24</label><mixed-citation publication-type="journal"><string-name><surname>Krych</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Thompson</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Knutson</surname>
<given-names>Z</given-names></string-name>, <string-name><surname>Scoon</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Coleman</surname>
<given-names>SH</given-names></string-name>. <article-title>Arthroscopic labral repair versus selective labral debridement in female patients with femoroacetabular impingement: a prospective randomized study</article-title>. <source>Arthroscopy</source><year>2013</year>;<volume>29</volume>:<fpage>46</fpage>&#x02013;<lpage>53</lpage>.<pub-id pub-id-type="pmid">23276413</pub-id></mixed-citation></ref><ref id="r25"><label>25</label><mixed-citation publication-type="journal"><string-name><surname>Schenker</surname>
<given-names>ML</given-names></string-name>, <string-name><surname>Martin</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Weiland</surname>
<given-names>DE</given-names></string-name>, <string-name><surname>Philippon</surname>
<given-names>MJ</given-names></string-name>. <article-title>Current trends in hip arthroscopy: a review of injury diagnosis, techniques, and outcome scoring</article-title>. <source>Curr Op Orthop</source><year>2005</year>;<volume>16</volume>:<fpage>89</fpage>&#x02013;<lpage>94</lpage>.</mixed-citation></ref><ref id="r26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Domb</surname>
<given-names>BG</given-names></string-name>, <string-name><surname>Stake</surname>
<given-names>CE</given-names></string-name>, <string-name><surname>Botser</surname>
<given-names>IB</given-names></string-name>, <string-name><surname>Jackson</surname>
<given-names>TJ</given-names></string-name>. <article-title>Surgical dislocation of the hip versus arthroscopic treatment of femoroacetabular impingement: a prospective matched-pair study with average 2-year follow-up</article-title>. <source>Arthroscopy</source><year>2013</year>;<volume>29</volume>:<fpage>1506</fpage>&#x02013;<lpage>1513</lpage>.<pub-id pub-id-type="pmid">23992988</pub-id></mixed-citation></ref><ref id="r27"><label>27</label><mixed-citation publication-type="journal"><string-name><surname>Reichmann</surname>
<given-names>WM</given-names></string-name>, <string-name><surname>Maillefert</surname>
<given-names>JF</given-names></string-name>, <string-name><surname>Hunter</surname>
<given-names>DJ</given-names></string-name>, <etal/>
<article-title>Responsiveness to change and reliability of measurement of radiographic joint space width in osteoarthritis of the knee: a systematic review</article-title>. <source>Osteoarthritis Cartilage</source><year>2011</year>;<volume>19</volume>:<fpage>550</fpage>&#x02013;<lpage>556</lpage>.<pub-id pub-id-type="pmid">21396469</pub-id></mixed-citation></ref><ref id="r28"><label>28</label><mixed-citation publication-type="journal"><string-name><surname>Altman</surname>
<given-names>RD</given-names></string-name>, <string-name><surname>Bloch</surname>
<given-names>DA</given-names></string-name>, <string-name><surname>Dougados</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group</article-title>. <source>Osteoarthritis Cartilage</source><year>2004</year>;<volume>12</volume>:<fpage>515</fpage>&#x02013;<lpage>524</lpage>.<pub-id pub-id-type="pmid">15219566</pub-id></mixed-citation></ref><ref id="r29"><label>29</label><mixed-citation publication-type="journal"><string-name><surname>Thorborg</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Roos</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Bartels</surname>
<given-names>EM</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>H&#x000f6;lmich</surname>
<given-names>P</given-names></string-name>. <article-title>Validity, reliability and responsiveness of patient-reported outcome questionnaires when assessing hip and groin disability: a systematic review</article-title>. <source>Br J Sports Med</source><year>2010</year>;<volume>44</volume>:<fpage>1186</fpage>&#x02013;<lpage>1196</lpage>.<pub-id pub-id-type="pmid">19666629</pub-id></mixed-citation></ref><ref id="r30"><label>30</label><mixed-citation publication-type="journal"><string-name><surname>Christensen</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>Althausen</surname>
<given-names>PL</given-names></string-name>, <string-name><surname>Mittleman</surname>
<given-names>MA</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JA</given-names></string-name>, <string-name><surname>McCarthy</surname>
<given-names>JC</given-names></string-name>. <article-title>The nonarthritic hip score: reliable and validated</article-title>. <source>Clin Orthop Relat Res</source><year>2003</year>;<volume>406</volume>:<fpage>75</fpage>&#x02013;<lpage>83</lpage>.<pub-id pub-id-type="pmid">12579003</pub-id></mixed-citation></ref><ref id="r31"><label>31</label><mixed-citation publication-type="journal"><string-name><surname>Mohtadi</surname>
<given-names>NG</given-names></string-name>, <string-name><surname>Griffin</surname>
<given-names>DR</given-names></string-name>, <string-name><surname>Pedersen</surname>
<given-names>ME</given-names></string-name>, <etal/>
<article-title>The development and validation of a self-administered quality-of-life outcome measure for young, active patients with symptomatic hip disease: the International Hip Outcome Tool (iHOT-33)</article-title>. <source>Arthroscopy</source><year>2012</year>;<volume>28</volume>:<fpage>595</fpage>&#x02013;<lpage>605</lpage>.<pub-id pub-id-type="pmid">22542433</pub-id></mixed-citation></ref><ref id="r32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Thorborg</surname>
<given-names>K</given-names></string-name>, <string-name><surname>H&#x000f6;lmich</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Christensen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Petersen</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Roos</surname>
<given-names>EM</given-names></string-name>. <article-title>The Copenhagen Hip and Groin Outcome Score (HAGOS): development and validation according to the COSMIN checklist</article-title>. <source>Br J Sports Med</source><year>2011</year>;<volume>45</volume>:<fpage>478</fpage>&#x02013;<lpage>491</lpage>.<pub-id pub-id-type="pmid">21478502</pub-id></mixed-citation></ref><ref id="r33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Dawson</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fitzpatrick</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Carr</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Murray</surname>
<given-names>D</given-names></string-name>. <article-title>Questionnaire on the perceptions of patients about total hip replacement</article-title>. <source>J Bone Joint Surg [Br]</source><year>1996</year>;<volume>78-B</volume>:<fpage>185</fpage>&#x02013;<lpage>190</lpage>.</mixed-citation></ref><ref id="r34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Freynhagen</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Baron</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Gockel</surname>
<given-names>U</given-names></string-name>, <string-name><surname>T&#x000f6;lle</surname>
<given-names>TR</given-names></string-name>. <article-title>painDETECT: a new screening questionnaire to identify neuropathic components in patients with back pain</article-title>. <source>Curr Med Res Opin</source><year>2006</year>;<volume>22</volume>:<fpage>1911</fpage>&#x02013;<lpage>1920</lpage>.<pub-id pub-id-type="pmid">17022849</pub-id></mixed-citation></ref><ref id="r35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Zigmond</surname>
<given-names>AS</given-names></string-name>, <string-name><surname>Snaith</surname>
<given-names>RP</given-names></string-name>. <article-title>The hospital anxiety and depression scale</article-title>. <source>Acta Psychiatr Scand</source><year>1983</year>;<volume>67</volume>:<fpage>361</fpage>&#x02013;<lpage>370</lpage>.<pub-id pub-id-type="pmid">6880820</pub-id></mixed-citation></ref><ref id="r36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Jaremko</surname>
<given-names>JL</given-names></string-name>, <string-name><surname>Lambert</surname>
<given-names>RG</given-names></string-name>, <string-name><surname>Zubler</surname>
<given-names>V</given-names></string-name>, <etal/>
<article-title>Methodologies for semiquantitative evaluation of hip osteoarthritis by magnetic resonance imaging: approaches based on the whole organ and focused on active lesions</article-title>. <source>J Rheumatol</source><year>2014</year>;<volume>41</volume>:<fpage>359</fpage>&#x02013;<lpage>369</lpage>.<pub-id pub-id-type="pmid">24241486</pub-id></mixed-citation></ref><ref id="r37"><label>37</label><mixed-citation publication-type="journal">EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life <source>Health Policy</source><year>1990</year>;<volume>16</volume>:<fpage>199</fpage>&#x02013;<lpage>208</lpage>.<pub-id pub-id-type="pmid">10109801</pub-id></mixed-citation></ref><ref id="r38"><label>38</label><mixed-citation publication-type="journal"><string-name><surname>Palmer</surname>
<given-names>AJ</given-names></string-name>, <string-name><surname>Brown</surname>
<given-names>CP</given-names></string-name>, <string-name><surname>McNally</surname>
<given-names>EG</given-names></string-name>, <etal/>
<article-title>Non-invasive imaging of cartilage in early osteoarthritis</article-title>. <source>Bone Joint J</source><year>2013</year>;<volume>95-B</volume>:<fpage>738</fpage>&#x02013;<lpage>746</lpage>.<pub-id pub-id-type="pmid">23723266</pub-id></mixed-citation></ref><ref id="r39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Lotz</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Martel-Pelletier</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Christiansen</surname>
<given-names>C</given-names></string-name>, <etal/>
<article-title>Value of biomarkers in osteoarthritis: current status and perspectives</article-title>. <source>Ann Rheum Dis</source><year>2013</year>;<volume>72</volume>:<fpage>1756</fpage>&#x02013;<lpage>1763</lpage>.<pub-id pub-id-type="pmid">23897772</pub-id></mixed-citation></ref><ref id="r40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Allen</surname>
<given-names>KD</given-names></string-name>. <article-title>The value of measuring variability in osteoarthritis pain</article-title>. <source>J Rheumatol</source><year>2007</year>;<volume>34</volume>:<fpage>2132</fpage>&#x02013;<lpage>2133</lpage>.<pub-id pub-id-type="pmid">17985413</pub-id></mixed-citation></ref><ref id="r41"><label>41</label><mixed-citation publication-type="journal"><string-name><surname>Egerton</surname>
<given-names>T</given-names></string-name>, <string-name><surname>Hinman</surname>
<given-names>RS</given-names></string-name>, <string-name><surname>Takla</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Bennell</surname>
<given-names>KL</given-names></string-name>, <string-name><surname>O'Donnell</surname>
<given-names>J</given-names></string-name>. <article-title>Intraoperative cartilage degeneration predicts outcome 12 months after hip arthroscopy</article-title>. <source>Clin Orthop Relat Res</source><year>2013</year>;<volume>471</volume>:<fpage>593</fpage>&#x02013;<lpage>599</lpage>.<pub-id pub-id-type="pmid">22992870</pub-id></mixed-citation></ref><ref id="r42"><label>42</label><mixed-citation publication-type="journal"><string-name><surname>Sipola</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Niemitukia</surname>
<given-names>LH</given-names></string-name>, <string-name><surname>Hyttinen</surname>
<given-names>MM</given-names></string-name>, <string-name><surname>Arokoski</surname>
<given-names>JP</given-names></string-name>. <article-title>Sample size for prospective studies of hip joint space width narrowing in osteoarthritis by the use of radiographs</article-title>. <source>Skeletal Radiol</source><year>2011</year>;<volume>40</volume>:<fpage>431</fpage>&#x02013;<lpage>438</lpage>.<pub-id pub-id-type="pmid">20740361</pub-id></mixed-citation></ref><ref id="r43"><label>43</label><mixed-citation publication-type="journal"><string-name><surname>Maheu</surname>
<given-names>E</given-names></string-name>, <string-name><surname>Cadet</surname>
<given-names>C</given-names></string-name>, <string-name><surname>Marty</surname>
<given-names>M</given-names></string-name>, <etal/>
<article-title>Reproducibility and sensitivity to change of various methods to measure joint space width in osteoarthritis of the hip: a double reading of three different radiographic views taken with a three-year interval</article-title>. <source>Arthritis Res Ther</source><year>2005</year>;<volume>7</volume>:<fpage>R1375</fpage>&#x02013;<lpage>R1385</lpage>.<pub-id pub-id-type="pmid">16277690</pub-id></mixed-citation></ref></ref-list></back></article>